Monthly Archives: November 2011

Patient Centeredness: Definitions Fuzzy,
Testing, Lawsuits Ahead #ECRI_FDA

Tweet Panel #2 – Lawyers are going to have a field day with what is patient centeredness. Jane Hyatt Thorpe, JD, Assoc. Research Prof. ACA – Medicare – care individual/population, average. IOM – patient centeredness refers to care – needs, … Continue reading

Posted in clinical trials, comparative effectiveness research, FDA, patient-centered outcomes research, patients | Tagged , | 1 Comment

Patient Centeredness in Policy & Practice:
Live from ECRI_FDA Meeting

Tweet Numerous challenges various entities are facing and building patient-centeredness. Panel #1: Susan Dentzer, Health Affairs, Margaret Hamburg, FDA Commissioner, MD, Carolyn Clancy, MD, Director, AHRQ, Joe V. Selby, MD, MPH, Executive Director, PCORI Hamburg: onslaught of HIV/AIDS epidemic in … Continue reading

Posted in Listening to patients, patient-centered outcomes research, patients | Tagged , | Comments Off on Patient Centeredness in Policy & Practice:
Live from ECRI_FDA Meeting

On Don Berwick and the Future of Healthcare Reform

Tweet I am supposed to be in a thankful mood, but I can’t help feeling that the bah-humbug mood has come early, with the forced departure of Don Berwick, head of the Centers for Medicare and Medicaid Services (CMS). Berwick … Continue reading

Posted in Healthcare reform | Tagged , , , , | Comments Off on On Don Berwick and the Future of Healthcare Reform

Who Knew?: HHS’ Less-than-Transparent
“Listening Sessions” on Essential Health Benefits

Tweet If you are listening, Health and Human Services (HHS), how about informing the public about the “Listening Sessions” on an Essential Health Benefits package on your website? Americans care about essential health benefits and HHS should be openly soliciting … Continue reading

Posted in Healthcare reform, transparency | Tagged , , , | Comments Off on Who Knew?: HHS’ Less-than-Transparent
“Listening Sessions” on Essential Health Benefits